NEOS Investment Management LLC Purchases 11,704 Shares of Agilent Technologies, Inc. $A

NEOS Investment Management LLC grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 46.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 36,857 shares of the medical research company’s stock after acquiring an additional 11,704 shares during the quarter. NEOS Investment Management LLC’s holdings in Agilent Technologies were worth $4,731,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Resona Asset Management Co. Ltd. grew its position in Agilent Technologies by 6.2% in the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the last quarter. CCLA Investment Management grew its holdings in shares of Agilent Technologies by 10.5% during the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after purchasing an additional 97,312 shares during the last quarter. Nuance Investments LLC increased its position in Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after purchasing an additional 9,628 shares in the last quarter. Osaic Holdings Inc. lifted its stake in Agilent Technologies by 35.5% in the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after purchasing an additional 17,817 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Agilent Technologies by 3.8% in the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after buying an additional 22,498 shares in the last quarter.

Analysts Set New Price Targets

A has been the subject of several research analyst reports. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. Robert W. Baird increased their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. The Goldman Sachs Group initiated coverage on Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. Finally, Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $164.50.

Insiders Place Their Bets

In related news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $126.89 on Thursday. The stock’s 50 day moving average is $136.84 and its 200 day moving average is $135.62. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The firm has a market cap of $35.89 billion, a P/E ratio of 27.77, a P/E/G ratio of 3.60 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the prior year, the firm posted $1.46 EPS. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.